A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer.

Abstract

BACKGROUND Acute radiation-induced esophagitis (ARIE) is one of main toxicities complicated by thoracic radiotherapy, influencing patients' quality of life and radiotherapy proceeding seriously. It is difficult to be cured rapidly so far. Our phase I trial preliminarily showed that EGCG may be a promising strategy in the treatment of ARIE. MATERIALS AND… (More)
DOI: 10.1016/j.radonc.2015.02.014

Topics

Statistics

050201520162017
Citations per Year

Citation Velocity: 18

Averaging 18 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Zhao2015APP, title={A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer.}, author={Hanxi Zhao and Peng Xie and Xiaolin Li and Wanqi Zhu and Xindong Sun and XiaoRong Sun and Xiaoting Chen and Ligang Xing and Jinming Yu}, journal={Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology}, year={2015}, volume={114 3}, pages={351-6} }